Independent Scoping Study indicates Triton’s Nicanda Hill resource, is a low technical risk, economically robust and commercially viable graphite project.
NPV10% of US$1,230 million (pre-tax).
IRR of 137% (pre-tax).
Scoping Study based 100% on Indicated Resource Classification utilizing a base-case mining inventory of 51Mt grading 12.4%TGC for a contained 6.3Mt graphite.
1.8Mtpa throughput plant resulting in average annual production of 210,000t graphite concentrate.
Production of premium quality flake graphite concentrates planned to commence in 2017 with an initial life of mine of 30 years, including 1 year construction period.
Free on Board cost Port of Pemba estimated at an average of US$315 per tonne. Vanadium credits currently not included in Scoping Study.
Estimated capital cost of US$110 million including US$10 million of contingency.
Payback period within less than 12 months of commission.
Pre-Feasibility Study scheduled to commence as a result of the positive Scoping Study results.
- Forums
- ASX - By Stock
- TON
- Ann: Nicanda Hill Scoping Study
Ann: Nicanda Hill Scoping Study, page-3
-
- There are more pages in this discussion • 179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TON (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.29M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $6.081K | 467.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 599999 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 32250 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 599999 | 0.012 |
3 | 1000000 | 0.011 |
5 | 1650000 | 0.010 |
3 | 236105 | 0.009 |
3 | 482500 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 32250 | 1 |
0.014 | 316152 | 4 |
0.015 | 540000 | 1 |
0.016 | 102122 | 1 |
0.017 | 78909 | 2 |
Last trade - 15.18pm 07/05/2024 (20 minute delay) ? |
Featured News
TON (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online